The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

BOSTON — The Endocrine Society has issued a new scientific statement advising clinicians to avoid using custom-compounded hormones to treat menopausal symptoms, female sexual dysfunction, and thyroid ...

NATIONAL HARBOR, Maryland — Anywhere from 1 million to 2.5 million women in the United States — about 2% of the female population older than 40 years — are using "bioidentical" compounded menopausal ...

When going through perimenopause and menopause, you’ll likely experience hot flashes, mood swings and other symptoms. This is because your body is changing and your hormone levels are fluctuating. To ...

The American Diabetes Association (ADA) urged healthcare providers against prescribing non-FDA approved compounded GLP-1 and dual GIP/GIP-1 receptor agonists for type 2 diabetes or obesity and instead ...

WASHINGTON — Government health officials have begun cracking down on Internet sales of custom-mixed hormones for menopausal women, a market born when doctors deemed prescription estrogen therapy too ...

From 28% to 68% of women using hormones at menopause take compounded, so-called "bioidentical" hormones, but women don't understand the risks of these unapproved, untested treatments, shows an ...

In 2025, menopause care has entered a new era, with groundbreaking drugs, refined hormone guidelines, and science-backed mind–body therapies transforming how women find relief. October’s World ...

CHICAGO -- The use of hormone therapy for menopause in the U.S. has remained low since 2007 when it first dropped, according to an analysis of insurance claims data. The prevalence of hormone therapy ...

Sabrina Martucci Johnson, President & Chief Executive Officer, highlighted a "recently announced expanded business strategy leveraging a dual path strategy where we commercialize our proprietary ...